Cargando…
Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has caused significant morbidity and mortality worldwide. Though previous coronaviruses have caused substantial epidemics in recent years, effective therapies remained limited at the start of the Coronavirus disease 19 (COVID-19) pandemic....
Autores principales: | Narayanan, Divya, Parimon, Tanyalak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319826/ https://www.ncbi.nlm.nih.gov/pubmed/35887042 http://dx.doi.org/10.3390/ijms23147702 |
Ejemplares similares
-
What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013) -
What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014) -
Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms
por: Fertonani, Anna, et al.
Publicado: (2016) -
Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases
por: Ibrahim, Abdulrahman, et al.
Publicado: (2021) -
What Do We Currently Know About Patellofemoral Osteochondritis Dissecans?
por: Bonaspetti, Giovanni, et al.
Publicado: (2022)